$4,616.90 consulting Payment -- Teva Pharmaceuticals to Dr. Amy Phillips

Pain Management Doctor Receives $4,616.90 Consulting Fee from Teva Pharmaceuticals for Wegovy

This page provides a detailed analysis of a $4,616.90 consulting payment from Teva Pharmaceuticals to Dr. Amy Phillips. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$4,616.90
Payment Typeconsulting
Payment NatureConsulting Fee
Pharmaceutical CompanyTeva Pharmaceuticals
PhysicianDr. Amy Phillips
NPI Number1264990338
Physician SpecialtyPain Management
LocationRochester, NY
Date of Payment2024-09-11
Related Drug/DeviceWegovy
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Teva Pharmaceuticals made a $4.6K consulting payment to Amy Phillips, a Pain Management specialist in Rochester, NY. The payment was associated with Wegovy. The payment of $4,616.90 to Dr. Amy Phillips from Teva Pharmaceuticals for consulting services is related to Wegovy. This payment occurred on September 11, 2024, and was made to a Pain Management specialist in Rochester, NY. The payment was specifically for a 'Consulting Fee' under the 'consulting' payment type.

Patient Guidance: What This Payment Means for You

If you are a patient of Dr. Phillips and are prescribed Wegovy, this payment information may be relevant to understanding potential influences on prescribing decisions. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Consulting fees for specialists can vary widely, but a payment of this nature for a specific drug consultation warrants review against typical industry benchmarks for Pain Management physicians.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act provisions of the Affordable Care Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $4.6K payment for?

This was a consulting payment of $4.6K from Teva Pharmaceuticals to Amy Phillips, categorized as "Consulting Fee". It was associated with Wegovy. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Amy Phillips accept pharmaceutical money?

Yes, Amy Phillips received this $4.6K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Amy Phillips's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $4.6K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pain Management?

To compare this payment against Pain Management averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pain Management physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Amy Phillips's relationship with Teva Pharmaceuticals?

The payment amount is a specific consulting fee, not a general research or speaking engagement. This $4.6K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pain Management?

The payment is linked to a specific drug, Wegovy, which is often used for weight management.

What should patients do after learning about this payment?

If you are a patient of Dr. Phillips and are prescribed Wegovy, this payment information may be relevant to understanding potential influences on prescribing decisions.

What else should I know about this consulting payment?

Dr. Phillips' specialty is Pain Management, which may or may not directly align with Wegovy's primary indications.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.